CLINICAL_TRIALS
trial_result
· 2012-07-13
Clinical Trial Update: HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer [Phase 2]
Summary
A Phase 2 study evaluating trastuzumab in combination with vinorelbine for metastatic breast cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute, Naples | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED